SK bioscience's Zoster Vaccine Receives Biologics License Application Approval in Malaysia
- Written by PR Newswire
![]() |
- The world-second developed shingles vaccine 'SKYZoster™' is approved by the National Pharmaceutical Regulatory Agency (NPRA)
- SK biosciences plans to launch the zoster vaccine with proven efficacy and safety starting in Southeast Asian market
SEOUL, South Korea, Jan. 9, 2023 /PRNewswire/ -- SK bioscience, a global innovative vaccine and...